| Literature DB >> 23062712 |
Elena Matyugina1, Anastasia Khandazhinskaya, Larisa Chernousova, Sofia Andreevskaya, Tatiana Smirnova, Alexander Chizhov, Inna Karpenko, Sergey Kochetkov, Ludmila Alexandrova.
Abstract
A series of new carbocyclic uracil derivatives were synthesized and evaluated as potential antituberculosis agents. Racemic 1-[4'-hydroxy-2'-cyclopenten-1'-yl]-5-tetradecynyluracil completely inhibited the growth of Mycobacterium tuberculosis H37Rv in vitro at a concentration of 10 μg/ml. Individual (+) and (-) isomers of the above uracil derivative were isolated and showed the same level of activity against two strains of Mycobacterium tuberculosis: laboratory sensitive (H37Rv) and clinical resistant to five top antituberculosis drugs (MS-115).Entities:
Mesh:
Substances:
Year: 2012 PMID: 23062712 DOI: 10.1016/j.bmc.2012.09.019
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641